It was outstanding news to hear today from the Australian Prime Minister Hon Anthony Albanese & Minister for Health Hon Mark Butler that the Federal Government would provide further support of brain cancer research.
The team funded by the Federal Government will be based at Chris OโBrien Lifehouse, Royal Prince Alfred Hospital and The University of Sydney.
Brain cancer is the commonest cause of death from cancer in people <40 years old in our country. Less than 5% of patients with some types of brain cancer survive 3 years and this hasnโt changed in >20 years. We have to change this and deliver on our goals of achieving zero brain cancer deaths and improve patient quality of life.
Prof Chris OโBrien AO was an inspiring, dedicated and brilliant clinician, educator & researcher. Early in my career, Chris and I co-authored some important research publications and worked together on clinical care of patients and junior staff education. Chrisโ knowledge, dedication and compassion inspired me from our first interactions in 1998 and have been with me ever since. When Chris was diagnosed with brain cancer in 2006, it shocked and saddened everyone at RPAH & beyond. But in the years after his diagnosis came to light, Chris continued to impact the community with his determination, courage, communication and talent. He was a wonderful human being who inspired a generation of people. Chris OโBrien still inspires me as I fight my own battle with brain cancer.
#glioblastoma
#Braincancer
@COBLH@SydneyLHD@Sydney_Uni
Words canโt express the heart of Professor Richard Scolyer.
His melanoma research has saved thousands of lives and his personal fight against his own deadly brain cancer has inspired millions.
Now, his legacy will live on through the Richard Scolyer Chair in Brain Cancer Research at the Chris OโBrien Lifehouse.
For everything youโve done, thank you Richard.
What has happened to Service NSW โฆ it used to be so efficient and customer focussed โฆ. estimated one and a half hour wait to have condition on my licence ( wearing glasses ) changed to no glasses needed โฆ. By the way , I still wear glasses at all times including driving
Filming for a documentary on need for a national anti-falls strategy to be released soon. Biggest problem in health of over-65s. Costs budget over 3 billion. Warrants national campaign like anti-smoking and skin cancer prevention.
Celebrating Prof Geoff McCaughanโs @geoff02461288 retirement at @SydneyLHD RPA Ground Rounds with @nahguaccm - who both started at RPA as medical students in 1971!
Tonight's @abcnews finance, after 2 days off getting knee nerves ablated (they deserved it). Graphs of productivity, wages, dollar, bond yield and full employment, from RBA's Marion Kohler (no relation ... I think).
https://t.co/wpIdGrNkCx
๐ ๐ง๐๐ฐ ๐ญ๐ซ๐๐๐ญ๐ฆ๐๐ง๐ญ ๐จ๐๐๐๐ซ๐ข๐ง๐ ๐ก๐จ๐ฉ๐ ๐ญ๐จ ๐ฉ๐๐ญ๐ข๐๐ง๐ญ๐ฌ ๐ฐ๐ข๐ญ๐ก ๐ฅ๐ฎ๐ง๐ ๐๐๐ง๐๐๐ซ
Until recently, treatment options were very limited for patients with advanced EGFR-mutated non-small cell lung cancer (NSCLC), whose cancer progressed after other treatments. Results from a new phase II clinical trial involving Chris OโBrien Lifehouse lung cancer specialist, Associate Professor Steven Kao, are offering additional hope to these patients, with a new drug (patritumab deruxtecan) demonstrating meaningful efficacy. The recent publication in the Journal of Clinical Oncology identified that this new drug may become a standard therapy for lung cancer in the future, with definitive phase III trials already underway.
As two of our fundamental organisational pillars: our research and our future, itโs important to share the work that our researchers are achieving every day. By contributing to existing academia, Chris OโBrien Lifehouse researchers are collaborating with the country and worldโs most innovative minds to innovate and transform cancer treatment and understanding.
Read the article here: https://t.co/M8IUc8O0Wf
#choosehope #coblh #research #lungcancer #cancer #treatment #clinician
๐๐๐ฏ๐จ๐ฅ๐ฎ๐ญ๐ข๐จ๐ง๐ข๐ฌ๐ข๐ง๐ ๐๐ซ๐๐ฅ ๐๐๐ง๐๐๐ซ ๐๐๐ซ๐: $2.5 ๐๐ข๐ฅ๐ฅ๐ข๐จ๐ง ๐๐๐๐๐ ๐๐ซ๐๐ง๐ญ ๐ ๐ฎ๐๐ฅ๐ฌ ๐๐ง๐ง๐จ๐ฏ๐๐ญ๐ข๐จ๐ง ๐๐ง๐ ๐ฅ๐๐ฎ๐ง๐๐ก ๐จ๐ ๐๐ก๐ ๐๐๐ง๐ญ๐ซ๐ ๐จ๐ ๐๐๐ฌ๐๐๐ซ๐๐ก ๐๐ฑ๐๐๐ฅ๐ฅ๐๐ง๐๐ ๐ ๐จ๐ซ ๐๐ฉ๐ฉ๐ฅ๐ข๐๐ ๐๐ง๐ง๐จ๐ฏ๐๐ญ๐ข๐จ๐ง๐ฌ ๐ข๐ง ๐๐ซ๐๐ฅ ๐๐๐ง๐๐๐ซ
Chris O'Brien Lifehouse welcomes the Australian Governmentโs announcement of this yearโs recipients in the Centres of Research Excellence (CRE) scheme. Head and Neck Surgeon and University of Sydney (@Sydney_Uni ) Professor Jonathan Clark AM (@jcBeyond5) received $2.5 million from The National Health and Medical Research Council (@nhmrc) to launch The Centre of Research Excellence for Applied Innovations in Oral Cancer.
The Centre of Research Excellence grant recognises the contribution Professor Clark's team is making to oral cancer research. There are three components to the program that they applied with:
1.Trying to reduce the effects of radical surgery on young patients by identifying different approaches, which ultimately aims to avoid these intrusive surgeries and their associated side effects. Understanding โwhy is the incidence of oral cancer rising in young patients?โ and identify drugs that may be a suitable alternative.
2.Using reconstructive surgery to improve the form and function of patients following radical surgery, so they can reduce side effects and return to productive lives sooner.
3.Using tissue engineering approaches to avoid the need for transferring patientโs own bone during jaw reconstruction.
โI think this is about recognising the contribution that our team is making to the quality of life for patients who have cancer in their mouth. Also, itโs showing the importance of multiple institutions working collaboratively together to achieve better outcomes for our patientsโฆ Itโs an enabling grant that will help us to get other grants in the future alsoโ. Professor Jonathan Clark AM.
The NHMRC's 2023 Centres of Research Excellence (CRE) scheme brings together outstanding researchers from various institutions who work collaboratively to find innovative and practical solutions for better health. If you would like to read more, head to this link https://t.co/DmINddUoaf
#choosehope #chrisobrienlifehouse #coblh #nhmrc #researchexcellence #cre #oralcancer #innovationsinoralcancer #oralcancerresearch
Discussing MY-PROMPT-2 on behalf of co-authors: randomised study evaluating real-time PROM reporting &
whether timely intervention in the management of symptoms & toxicities will improve EFS by optimising duration of therapy #MRDR#IMS23@MyelomaAmarc@erica_m_wood@MMKingT
Today we had the honour of hosting The Hon. Chris Minns, (@ChrisMinnsMP) Premier of New South Wales, and The Hon. Ryan Park (@RyanPark_Keira), NSW Minister for Health to showcase our clinical, research, and holistic facilities. Throughout the tour, the Premier and Minister for Health were able to learn more about the comprehensive services that we offer here, and see firsthand the groundbreaking work being accomplished at our Integrated Prosthetics Reconstruction Lab, and the Arto Hardy Family Biomedical Innovation Hub. Weโre grateful for the opportunity to engage in meaningful conversations with our healthcare leaders, and look for ways that we can work together and enable greater collaboration in the future. Thank you to The Hon. Chris Minns and The Hon. Ryan Park for your time this morning.
#choosehope #chrisobrienlifehouse #coblh @coblh #innovation #research #sydney